Tranexamic acid use linked to decreased incidence of heterotopic ossification after elbow trauma surgery

FHS
June 22, 2023
2:57 pm

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common complication of abnormal bone formation, reports a study in The Journal of Bone & Joint Surgery.

Study finds pressure to be “perfect” leads to unhealthy impacts on both parents and their children

What does it take to help a parent avoid and manage burnout? Experts at Ohio State University came together to design a study on triggers

May 10, 2024

AI’s health misinformation challenge: Study calls for stronger safeguards and transparency

Study uncovers that current safeguards against health disinformation in large language models (LLMs) are applied inconsistently, and AI developers lack transparency in their risk mitigation

March 25, 2024

Risk adjusted net present value: What is the current valuation of Biomea Fusion’s Icovamenib?

Icovamenib is a small molecule commercialized by Biomea Fusion, with a leading Phase II program in Type 2 Diabetes.

November 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.